Profil
Michael Warner worked as Lead Counsel-Medicinal Chemistry & Pharmaceutical at Pfizer Inc. from 2000 to 2016.
He then worked as Assistant General Counsel & Head-Legal Site at Rinat Neuroscience Corp.
and as Lead Attorney at RaQualia Pharma, Inc. In 2016, he joined ALX Oncology Holdings, Inc. as General Counsel, a position he held until 2022.
Dr. Warner received his undergraduate degree from Centenary College of Louisiana, his doctorate from Indiana University, and his graduate degree from St. Louis University.
Ehemalige bekannte Positionen von Michael Warner
| Unternehmen | Position | Ende |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | General Counsel | 01.02.2022 |
| PFIZER INC. | Corporate Officer/Principal | 01.01.2016 |
| RAQUALIA PHARMA INC. | Corporate Officer/Principal | - |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Corporate Officer/Principal | - |
Ausbildung von Michael Warner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Centenary College of Louisiana
Centenary College of Louisiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
RaQualia Pharma, Inc.
RaQualia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development of medicines | Health Technology |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
















